IL-4, IL-10 and IL-13 modulate Aβ(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line

Journal of Neuroimmunology

Volumn 113, Issue 1, 2001, Pages 49-62

  Szczepanik, Ann Marie ^a   Funes, Sandrine ^a   Petko, Wayne ^a   Ringheim, Garth E ^a  

^a SANOFI   (France)

Author keywords

Alzheimer's disease; Amyloid; Interleukin 10; Interleukin 13; Interleukin 4; Microglia

Indexed keywords

AMYLOID BETA PROTEIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; MACROPHAGE; MICROGLIA; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CELL LINE; CHEMOKINE CCL2; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKINS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED STRAINS; MICROGLIA; MONOCYTES; PEPTIDE FRAGMENTS; RNA, MESSENGER; SENILE PLAQUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035255055     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00404-5     Document Type: Article

References (103)

1. Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. Localization and cell association of C1q in Alzheimer's disease brain
3. Engagement of the scavenger receptor is not responsible for beta-amyloid stimulation of monocytes to a neurocytopathic state
4. β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease
5. 2+ and intracellular acidification
6. Interleukin-1 and tumor necrosis factor-mediated regulation of C3 gene expression in human astroglioma cells
7. Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression
8. The microglial cell. A historical review
9. In-vitro matured human macrophages express Alzheimer's beta A4-amyloid precursor protein indicating synthesis in microglial cells
10. Patterns of gliosis in Alzheimer's disease and aging cerebrum
11. Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines
12. TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs
13. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs
14. Membrane IL-1: IL-1α precursor binds to the plasma membrane via a lectin-like interaction
15. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia
16. Serum tumor necrosis factor (TNF) in Alzheimer's disease and multi-infarct dementia
17. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6
18. Tumor necrosis-α potentiates glutamate neurotoxicity in human fetal brain cell cultures
19. Neuroprotective role of IL-4 against activated microglia
20. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity; involvement of nitric oxide and of N-methyl-d-aspartate receptors
21. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: Complement activation and therapeutic approaches
22. General and dramatic glial reaction in Alzheimer's brains
23. The pathogenesis of senile plaques
24. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease
25. Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production
26. Inhibition of IL-10 expression by IFN-γ up-regulates transcription of TNF-αin human monocytes
27. Glial fibrillary acidic protein and Alzheimer-type senile dementia
28. Scavenger receptor-mediated adhesion of microglia to b-amyloid fibrils
29. Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type
30. LPS-binding proteins and receptors
31. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model
32. Elevated circulating tumor necrosis factor levels in Alzheimer's disease
33. Beta-amyloid fragment potentiates IL-6 and TNF-alpha secretion by LPS in astrocytes but not in microglia
34. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1
35. Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzeheimer's disease patients
36. Microglia and neuronal dysfunction
37. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia
38. The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease
39. Interleukin-1 regulates synthesis of amyloidβ-protein precursor mRNA in human endothelial cells
40. Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ
41. Integrin Mac-1 and beta-amyloid in microglial release of nitric oxide
42. Inflammatory pathways: Implications in Alzheimer's disease
43. Brain interleukin1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
44. Synthetic Alzheimer amyloid β/A4 peptide enhances production of complement C3 component by cultured microglial cells
45. Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release
46. Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility on vitro
47. β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity
48. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease
49. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease
50. Visualization of Aβ42(43) and Aβ40 in Down's syndrome
51. Seeding 'one-dimensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
52. Biological activity and receptor binding of human prointerleukin-1βand subpeptides
53. Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and Alzheimer's disease
54. Cord-blood-derived human cultured mast cells produce interleukin 13 in the presence of stem cell factor
55. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices
56. β-Amyloid protein enhances macrophage production of oxygen free radicals and glutamate
57. Activation of macrophages by Alzheimer β amyloid peptide
58. 2+ concentration in cultured rat microglia
59. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: Interleukin-1 beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha 1-antichymotrypsin
60. Systemic changes of the immune system in patients with Alzheimer's dementia
61. Specific endotoxic lipopolysaccharide-binding receptors on murine splenocytes. III. Binding specificity and characterization
62. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: Peripheral inflammation or signals from the brain?
63. β-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes
64. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia
65. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR
66. Immune system response in Alzheimer's disease
67. Prevalence of dementia amongst elderly Japanese with leprosy: Apparent effect of chronic drug therapy
68. Activation of microglial cells by β-amyloid protein and interferon-γ
69. β-Amyloid (25-35) peptide and IFNγ-synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells
70. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]
71. The interleukin-1 receptor binds the human interleukin-1αprecursor but not the interleukin-1βprecursor
72. Microglial cells internalized aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor
73. Macrophages and the nervous system
74. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
75. Neurodegeneration induced byβ-amyloid peptides in vitro: The role of peptide assembly state
76. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease
77. Additive effects of basic fibroblast growth factor and phorbol ester onβ-amyloid precursor protein expression and secretion
78. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease
79. Clinical trial of indomethacin in Alzheimer's disease
80. Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences
81. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
82. IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1
83. In vitro production of IL-6, IL-1beta, and tumor necrosis factor-alpha by embryonic microglial and neural cells
84. Cell biology of the amyloidβ-protein precursor and the mechanism of Alzheimer's disease
85. β-Amyloid peptide induces tumor necrosis factor-α and nitric oxide production in murine macrophage cultures
86. Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vivo
87. Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes: Morphology
88. Synergism between platelet activating factor and C-C chemokines for arachidonate release in human monocytes
89. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients
90. Molecular, cellular and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain
91. Endotoxin signal transduction in macrophages
92. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices
93. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester
94. Amyloidβ protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity
95. The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages
96. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains
97. Complement component C1Q modulates the phagocytosis of Abeta by microglia
98. IL-10 production by adult human derived microglial cells
99. Cytokine indices in Alzheimer's temporal cortex: No changes in mature IL-1β or IL-RA but increases in the associated acute phase proteins IL-6α, 2-macroglobulin and C-reactive protein
100. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease
101. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
102. Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia
103. Molecular neurobiology of Alzheimer's disease (Syndrome?)